Cellyan Biotechnology Co., Ltd (HKPD) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Cellyan Biotechnology Co., Ltd (HKPD) operates in the Healthcare sector, specifically the Medical - Pharmaceuticals industry, with a market capitalization near $5.9M, listed on NASDAQ, employing roughly 27 people, carrying a beta of 2.63 to the broader market. Cellyan Biotechnology Co. Led by Chenyu Liang, public since 2025-01-15.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for HKPD as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →